Paper41482575
The immunology of vitiligo.
Turk MJ and 1 other. Nat Rev Immunol, 2026. Cited by 5 papers, by iCite.
Cite this record
ConductScience Library. The immunology of vitiligo. Papers, record 41482575. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41482575
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Vitiligo | Major topic |
| Melanocytes | Major topic |
| Humans | |
| Animals | |
| CD8-Positive T-Lymphocytes | |
| Autoimmune Diseases | |
| Mice | |
| Autoimmunity |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| P30 CA023108 | NCI NIH HHS | United States | P30CA023108 | PubMed | NIH RePORTER |
| R01 CA225028 | NCI NIH HHS | United States | R01CA225028 | PubMed | NIH RePORTER |
| R01 CA254042 | NCI NIH HHS | United States | R01CA254042 | PubMed | NIH RePORTER |
References179
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 14172076 | VITILIGO IN A CASE OF VACCINIA VIRUS-TREATED MELANOMA. | Cancer | 1964 | https://conductscience.org/library/papers/14172076 | PubMed |
| 2 | 24935676 | Immune responses in a mouse model of vitiligo with spontaneous epidermal de- and repigmentation. | Pigment Cell Melanoma Res | 2014 | https://conductscience.org/library/papers/24935676 | PubMed |
| 3 | 23702581 | Wnt/β-catenin and kit signaling sequentially regulate melanocyte stem cell differentiation in UVB-induced epidermal pigmentation. | J Invest Dermatol | 2013 | https://conductscience.org/library/papers/23702581 | PubMed |
| 4 | 24107643 | Comorbidities associated with vitiligo: a ten-year retrospective study. | Dermatology | 2013 | https://conductscience.org/library/papers/24107643 | PubMed |
| 5 | 19242513 | Autoimmune destruction of skin melanocytes by perilesional T cells from vitiligo patients. | J Invest Dermatol | 2009 | https://conductscience.org/library/papers/19242513 | PubMed |
| 6 | 16911396 | Increased tumor necrosis factor alpha (TNF-alpha) and interleukin 1 alpha (IL1-alpha) levels in the lesional skin of patients with nonsegmental vitiligo. | Int J Dermatol | 2006 | https://conductscience.org/library/papers/16911396 | PubMed |
| 7 | 11511311 | Specific cytotoxic T lymphocyte responses against Melan-A/MART1, tyrosinase and gp100 in vitiligo by the use of major histocompatibility complex/peptide tetramers: the role of cellular immunity in the etiopathogenesis of vitiligo. | J Invest Dermatol | 2001 | https://conductscience.org/library/papers/11511311 | PubMed |
| 8 | 23251420 | Transcriptome analysis reveals markers of aberrantly activated innate immunity in vitiligo lesional and non-lesional skin. | PLoS One | 2012 | https://conductscience.org/library/papers/23251420 | PubMed |
| 9 | 26501224 | Association of Vitiligo With Tumor Response in Patients With Metastatic Melanoma Treated With Pembrolizumab. | JAMA Dermatol | 2016 | https://conductscience.org/library/papers/26501224 | PubMed |
| 10 | 29580869 | Inverse Relationship between Vitiligo-Related Genes and Skin Cancer Risk. | J Invest Dermatol | 2018 | https://conductscience.org/library/papers/29580869 | PubMed |
| 11 | 23447019 | Mutant HSP70 reverses autoimmune depigmentation in vitiligo. | Sci Transl Med | 2013 | https://conductscience.org/library/papers/23447019 | PubMed |
| 12 | 37680638 | Insight into immune profile associated with vitiligo onset and anti-tumoral response in melanoma patients receiving anti-PD-1 immunotherapy. | Front Immunol | 2023 | https://conductscience.org/library/papers/37680638 | PubMed |
| 13 | 20175879 | Reduced skin homing by functional Treg in vitiligo. | Pigment Cell Melanoma Res | 2010 | https://conductscience.org/library/papers/20175879 | PubMed |
| 14 | 38439216 | Topical antibiotics limit depigmentation in a mouse model of vitiligo. | Pigment Cell Melanoma Res | 2024 | https://conductscience.org/library/papers/38439216 | PubMed |
| 15 | 17243956 | Association of vitiligo with HLA-A2: a meta-analysis. | J Eur Acad Dermatol Venereol | 2007 | https://conductscience.org/library/papers/17243956 | PubMed |
| 16 | 34179824 | Resident and circulating memory T cells persist for years in melanoma patients with durable responses to immunotherapy. | Nat Cancer | 2021 | https://conductscience.org/library/papers/34179824 | PubMed |
| 17 | 25576595 | The inducible costimulator augments Tc17 cell responses to self and tumor tissue. | J Immunol | 2015 | https://conductscience.org/library/papers/25576595 | PubMed |
| 18 | 22458952 | A review of the worldwide prevalence of vitiligo in children/adolescents and adults. | Int J Dermatol | 2012 | https://conductscience.org/library/papers/22458952 | PubMed |
| 19 | 15728460 | Regulated folding of tyrosinase in the endoplasmic reticulum demonstrates that misfolded full-length proteins are efficient substrates for class I processing and presentation. | J Immunol | 2005 | https://conductscience.org/library/papers/15728460 | PubMed |
| 20 | 30026331 | Oncogenic BRAFV600E Governs Regulatory T-cell Recruitment during Melanoma Tumorigenesis. | Cancer Res | 2018 | https://conductscience.org/library/papers/30026331 | PubMed |
Cited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42984631 | Case Report: Dupilumab-associated psoriasiform eruption followed by depigmentation in a patient with prurigo nodularis and Vogt-Koyanagi-Harada disease. | Front Immunol | 2026 | https://conductscience.org/library/papers/42984631 | PubMed |
| 42903092 | Vitiligo onset following anti-inflammatory biological therapy: a scoping review. | Front Immunol | 2026 | https://conductscience.org/library/papers/42903092 | PubMed |
| 42857697 | Oxidative stress in refractory and recurrent vitiligo: from immune amplification mechanisms to potential stratified antioxidant combination therapy. | Front Immunol | 2026 | https://conductscience.org/library/papers/42857697 | PubMed |
| 42812837 | Gut and skin microbiome-metabolome pathways in vitiligo: from dysbiosis to immune activation and melanocyte dysfunction. | Front Immunol | 2026 | https://conductscience.org/library/papers/42812837 | PubMed |
| 42801089 | Hotspots and Emerging Trends in JAK Inhibitor Therapy for Vitiligo: A Bibliometric Analysis (2015-2025). | J Inflamm Res | 2026 | https://conductscience.org/library/papers/42801089 | PubMed |
| 42441140 | CD8+ Tissue-Resident Memory T Cells in Health and Disease. | MedComm (2020) | 2026 | https://conductscience.org/library/papers/42441140 | PubMed |
| 42191963 | IFN-producing myeloid cells mediate photosensitivity. | Nat Immunol | 2026 | https://conductscience.org/library/papers/42191963 | PubMed |
| 42144579 | IL-21 rs2055979 and serum IL-21 levels are associated with both non-segmental and segmental vitiligo in an Iranian cohort. | BMC Immunol | 2026 | https://conductscience.org/library/papers/42144579 | PubMed |
| 42123379 | Lactate Enhances CD8+ T Cell Cytotoxicity Through H3K9la Upregulation to Drive Vitiligo Pathogenesis. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42123379 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| CD8A | 925 | PubTator's text mining | https://conductscience.org/library/genes/925 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41482575
GET https://conductscience.org/api/papers/v1/41482575/references?page=2